Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol.
about
Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone.Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude miceVitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris.Cyclin D1 and cancer development in laryngeal premalignancy patients.Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemia.Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.Chemoprevention of lung cancer: concepts and strategies.Bionutrition and oral cancer in humans.Allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.Differentiation therapy of myelodysplastic syndromes with retinoic acid.The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.Effects of isotretinoin on serum vitamin E levels in patients with acne.Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haemopoietic growth factors
P2860
Q33333267-0A7434DF-1CFF-4CB8-BC83-D40898C27620Q33765524-B435A207-DF76-4D96-BD70-A1FA0375CC12Q34556447-C2C420BD-5341-40DF-82A8-BB7FB7FD6A54Q34569485-C6A7F202-AAC8-44D5-8709-A776F5A739E9Q34742369-6FDE45C8-5365-4B3E-8664-95C873B72C99Q35307851-5952DE31-84DB-481F-A5EA-BBF060E85478Q36185641-386E750C-6A2D-4B60-ABAD-967628C497BBQ40458905-251BF3DC-A604-436A-BEF3-0254FD0EC3B4Q40563643-88CFE317-BFD0-4AE2-B38E-F2C49F57FE61Q40563661-78255333-6E49-421E-AFA9-F6AE5CE9BA37Q40839068-63CCD9EF-D470-4587-89FC-A129C76E78CDQ51256249-237A4BCD-2C89-4AAE-8951-CCCE68381C1CQ58414503-88F4809B-A96A-41B9-9F99-1BB2A3DA3EDF
P2860
Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol.
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@ast
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@en
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@nl
type
label
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@ast
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@en
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@nl
prefLabel
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@ast
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@en
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@nl
P2093
P1476
Treatment with 13-cis-retinoic ...... addition of alpha-tocopherol.
@en
P2093
Bartholomew MJ
Hyzinski M
P304
P356
10.1016/0002-9343(90)90215-Y
P407
P577
1990-12-01T00:00:00Z